Contemporary Views of Prophylactic Administration of Haemopoietic Growth Factors of theGranulocyte Series during Standard Dosage Chemotherapy
Authors:
J. Štěrba; D. Dembická
Authors‘ workplace:
Oddělení dětské onkologie FN Brno, Fakultní dětská nemocnice J. G. Mendela, primář MUDr. J. Štěrba
Published in:
Čes-slov Pediat 1999; (9): 490-495.
Category:
Overview
During the last decade recombinant DNA technologies have facilitated development and production ofhaemopoietic growth factor (colony stimulating factors - CSF) which stimulate the proliferation and maturationof haematopoietic cells. CSF (mainly granulocyte and granulocyte macrophage CSF) in children is widely useddespite the absence of conclusive supportive data, and despite the high cost of these d rugs.This review is devoted to one of the most controversial, but most common reason for their use prophylactic use.A summary of recomended uses of the CSF in paediatric oncology is presented praxis and relevant clinical studiesare discussed.
Key words:
haemopoietic growth factors (CSF), use in child oncology
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
1999 Issue 9
Most read in this issue
- Bronchodilation after Metered Dose of „Berodual“ Aerosol in Asthmatic Children - Effect ofa Spacer
- Tularaemia - one of the Less Common Causes of Nodular Syndrome and Pulmonary Affectionin Childhood
- Attention Deficit Hyperactivity Disorder (ADHD): Advances in Cognitive, Neurobiologicaland Genetic Research
- Diagnosis of Non-palpable Testicle in Children